These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6201198)
1. Reduction of norepinephrine turnover by serotonergic drug in man. Rudorfer MV; Scheinin M; Karoum F; Ross RJ; Potter WZ; Linnoila M Biol Psychiatry; 1984 Feb; 19(2):179-93. PubMed ID: 6201198 [TBL] [Abstract][Full Text] [Related]
2. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments. Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178 [TBL] [Abstract][Full Text] [Related]
3. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients. Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234 [TBL] [Abstract][Full Text] [Related]
4. The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes. Karoum F; Korpi ER; Chuang LW; Linnoila M; Wyatt RJ Eur J Pharmacol; 1986 Mar; 121(3):377-85. PubMed ID: 2422047 [TBL] [Abstract][Full Text] [Related]
5. Interconversion of O-methylated norepinephrine metabolites in humans. Brown RT; Polinsky RJ; Kopin IJ J Lab Clin Med; 1987 Jul; 110(1):119-24. PubMed ID: 3598334 [TBL] [Abstract][Full Text] [Related]
6. Electroconvulsive treatment and lithium carbonate. Their effects on norepinephrine metabolism in patients with primary, major depressions. Linnoila M; Karoum F; Rosenthal N; Potter WZ Arch Gen Psychiatry; 1983 Jun; 40(6):677-80. PubMed ID: 6221709 [TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of fluoxetine and haloperidol on mouse brain serotonin and norepinephrine turnover. Hall LM; Anderson GM; Cohen DJ Life Sci; 1995; 57(8):791-801. PubMed ID: 7543647 [TBL] [Abstract][Full Text] [Related]
8. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH. Grossman F; Potter WZ Psychiatry Res; 1999 Jul; 87(1):21-7. PubMed ID: 10512151 [TBL] [Abstract][Full Text] [Related]
9. Common mechanism of action of biochemically "specific" antidepressants. Potter WZ; Karoum F; Linnoila M Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):153-61. PubMed ID: 6233636 [TBL] [Abstract][Full Text] [Related]
11. Central and peripheral noradrenergic tone in primary hypertension. DeQuattro V; Sullivan P; Minagawa R; Kopin I; Bornheimer J; Foti A; Barndt R Fed Proc; 1984 Jan; 43(1):47-51. PubMed ID: 6690337 [TBL] [Abstract][Full Text] [Related]
12. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Bondi CO; Barrera G; Lapiz MD; Bedard T; Mahan A; Morilak DA Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):482-95. PubMed ID: 17188790 [TBL] [Abstract][Full Text] [Related]
13. Studies of amine metabolites in depressed patients. Relationship to suicidal behavior. Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis JH; Maas JW Ann N Y Acad Sci; 1986; 487():231-42. PubMed ID: 2436536 [No Abstract] [Full Text] [Related]
14. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. Koslow SH; Maas JW; Bowden CL; Davis JM; Hanin I; Javaid J Arch Gen Psychiatry; 1983 Sep; 40(9):999-1010. PubMed ID: 6193764 [TBL] [Abstract][Full Text] [Related]
15. Indices of noradrenergic output in depression. Siever LJ; Uhde TW; Jimerson DC; Lake CR; Kopin IJ; Murphy DL Psychiatry Res; 1986 Sep; 19(1):59-73. PubMed ID: 3786600 [TBL] [Abstract][Full Text] [Related]
16. Catecholamine metabolites in spinal cord injury. Harvey RF; Fullerton DT; Carlson IH; Klein MH; Howell T Arch Phys Med Rehabil; 1982 Sep; 63(9):419-22. PubMed ID: 7115040 [TBL] [Abstract][Full Text] [Related]
17. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans. Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832 [TBL] [Abstract][Full Text] [Related]
18. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls. Roy A; Guthrie S; Karoum F; Pickar D; Linnoila M Arch Gen Psychiatry; 1988 Feb; 45(2):158-61. PubMed ID: 3337613 [TBL] [Abstract][Full Text] [Related]
19. Effects of clonidine on central and peripheral catecholamine metabolism. Martin PR; Ebert MH; Gordon EK; Linnoila M; Kopin IJ Clin Pharmacol Ther; 1984 Mar; 35(3):322-7. PubMed ID: 6199153 [TBL] [Abstract][Full Text] [Related]
20. Differences in lithium effects in depressed and healthy subjects. Rudorfer MV; Karoum F; Ross RJ; Potter WZ; Linnoila M Clin Pharmacol Ther; 1985 Jan; 37(1):66-71. PubMed ID: 2578106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]